{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T09:03:41Z","timestamp":1780995821984,"version":"3.54.1"},"reference-count":94,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"The Postgraduate Research & Practice Innovation Program of Jiangsu Province","award":["KYCX25_3955"],"award-info":[{"award-number":["KYCX25_3955"]}]},{"name":"The Postgraduate Research & Practice Innovation Program of Jiangsu Province","award":["KYCX25_3954"],"award-info":[{"award-number":["KYCX25_3954"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12088-z","type":"journal-article","created":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T08:33:37Z","timestamp":1780994017000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Splenic treg-related immunoregulation in the spleen\u2013brain axis of alzheimer\u2019s disease: mechanisms and translational strategies"],"prefix":"10.1007","volume":"53","author":[{"given":"Mingzheng","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yahong","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingjie","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengyu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiguan","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,9]]},"reference":[{"issue":"2","key":"12088_CR1","doi-asserted-by":"publisher","first-page":"e105","DOI":"10.1016\/s2468-2667(21)00249-8","volume":"7","author":"Estimation of the global prevalence of dementia","year":"2022","unstructured":"Estimation of the global prevalence of dementia (2022) in 2019 and forecasted prevalence in 2050: An analysis for the global burden of disease study 2019. Lancet Public health 7(2):e105\u2013e125. https:\/\/doi.org\/10.1016\/s2468-2667(21)00249-8","journal-title":"Lancet Public health"},{"key":"12088_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2025.1585711","volume":"13","author":"Z Xiaopeng","year":"2025","unstructured":"Xiaopeng Z et al (2025) Global burden of Alzheimer\u2019s disease and other dementias in adults aged 65 years and older, 1991\u20132021: Population-based study. Front Public Health 13:1585711. https:\/\/doi.org\/10.3389\/fpubh.2025.1585711","journal-title":"Front Public Health"},{"issue":"4","key":"12088_CR3","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack","year":"2018","unstructured":"Jack CR Jr. et al (2018) NIA-AA research framework: Toward a biological definition of Alzheimer\u2019s disease. Alzheimers Dement 14(4):535\u2013562. https:\/\/doi.org\/10.1016\/j.jalz.2018.02.018","journal-title":"Alzheimers Dement"},{"issue":"1","key":"12088_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-021-00269-y","volume":"7","author":"DS Knopman","year":"2021","unstructured":"Knopman DS et al (2021) Alzheimer disease. Nat Rev Dis Primers 7(1):33. https:\/\/doi.org\/10.1038\/s41572-021-00269-y","journal-title":"Nat Rev Dis Primers"},{"issue":"8","key":"12088_CR5","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1016\/j.neuron.2024.01.013","volume":"112","author":"A Ramakrishnan","year":"2024","unstructured":"Ramakrishnan A et al (2024) Epigenetic dysregulation in Alzheimer\u2019s disease peripheral immunity. Neuron 112(8):1235-1248e.e1235. https:\/\/doi.org\/10.1016\/j.neuron.2024.01.013","journal-title":"Neuron"},{"issue":"6","key":"12088_CR6","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1038\/s41380-023-02355-x","volume":"29","author":"C Li","year":"2024","unstructured":"Li C et al (2024) Peripheral immune function and Alzheimer\u2019s disease: A living systematic review and critical appraisal. Mol Psychiatry 29(6):1895\u20131905. https:\/\/doi.org\/10.1038\/s41380-023-02355-x","journal-title":"Mol Psychiatry"},{"issue":"2","key":"12088_CR7","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1093\/brain\/awae230","volume":"148","author":"H Cai","year":"2025","unstructured":"Cai H et al (2025) Systemic inflammatory markers in ageing, Alzheimer\u2019s disease and other dementias. Brain 148(2):480\u2013492. https:\/\/doi.org\/10.1093\/brain\/awae230","journal-title":"Brain"},{"issue":"5","key":"12088_CR8","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/s43587-023-00403-3","volume":"3","author":"O Hansson","year":"2023","unstructured":"Hansson O, Blennow K, Zetterberg H, Dage J (2023) Blood biomarkers for alzheimer\u2019s disease in clinical practice and trials. Nat aging 3(5):506\u2013519. https:\/\/doi.org\/10.1038\/s43587-023-00403-3","journal-title":"Nat aging"},{"issue":"4","key":"12088_CR9","doi-asserted-by":"publisher","first-page":"e228392","DOI":"10.1001\/jamanetworkopen.2022.8392","volume":"5","author":"Y Hu","year":"2022","unstructured":"Hu Y et al (2022) Assessment of a plasma amyloid probability score to estimate amyloid positron emission tomography findings among adults with cognitive impairment. JAMA Netw Open 5(4):e228392\u2013e228392. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.8392","journal-title":"JAMA Netw Open"},{"issue":"1","key":"12088_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-024-03475-z","volume":"22","author":"R Singh","year":"2024","unstructured":"Singh R et al (2024) Circulating small extracellular vesicles in Alzheimer\u2019s disease: a case-control study of neuro-inflammation and synaptic dysfunction. BMC Med 22(1):254. https:\/\/doi.org\/10.1186\/s12916-024-03475-z","journal-title":"BMC Med"},{"issue":"1","key":"12088_CR11","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13073-023-01155-w","volume":"15","author":"M Jorfi","year":"2023","unstructured":"Jorfi M, Maaser-Hecker A, Tanzi RE (2023) The neuroimmune axis of alzheimer\u2019s disease. Genome Med 15(1):6. https:\/\/doi.org\/10.1186\/s13073-023-01155-w","journal-title":"Genome Med"},{"key":"12088_CR12","doi-asserted-by":"publisher","DOI":"10.14336\/ad.2025.1537","author":"Y Kim","year":"2026","unstructured":"Kim Y et al (2026) Organ-brain axis in alzheimer\u2019s disease: A systemic perspective on pathogenesis and progression. Aging disease. https:\/\/doi.org\/10.14336\/ad.2025.1537","journal-title":"Aging disease"},{"issue":"1","key":"12088_CR13","doi-asserted-by":"publisher","DOI":"10.1007\/s11481-025-10177-7","volume":"20","author":"AF Cantone","year":"2025","unstructured":"Cantone AF et al (2025) Rebalancing immune interactions within the brain-spleen axis mitigates neuroinflammation in an aging mouse model of Alzheimer\u2019s disease. J Neuroimmune Pharmacol 20(1):15. https:\/\/doi.org\/10.1007\/s11481-025-10177-7","journal-title":"J Neuroimmune Pharmacol"},{"issue":"1","key":"12088_CR14","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13533","volume":"21","author":"ZY Yu","year":"2022","unstructured":"Yu ZY et al (2022) Physiological clearance of a\u03b2 by spleen and splenectomy aggravates Alzheimer-type pathogenesis. Aging Cell 21(1):e13533. https:\/\/doi.org\/10.1111\/acel.13533","journal-title":"Aging Cell"},{"issue":"11","key":"12088_CR15","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/s41577-023-00857-x","volume":"23","author":"YO Alexandre","year":"2023","unstructured":"Alexandre YO, Mueller SN (2023) Splenic stromal niches in homeostasis and immunity. Nat Rev Immunol 23(11):705\u2013719. https:\/\/doi.org\/10.1038\/s41577-023-00857-x","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"12088_CR16","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s00441-025-04001-0","volume":"402","author":"R Pabst","year":"2025","unstructured":"Pabst R (2025) Clinical relevance of the compartments and lymphocyte subsets in the human spleen. Cell Tissue Res 402(1):109\u2013119. https:\/\/doi.org\/10.1007\/s00441-025-04001-0","journal-title":"Cell Tissue Res"},{"issue":"9","key":"12088_CR17","doi-asserted-by":"publisher","first-page":"3034","DOI":"10.1093\/brain\/awaf288","volume":"148","author":"D Skelly","year":"2025","unstructured":"Skelly D, Attfield KE, Fugger L (2025) T cells turn in alzheimer\u2019s disease. Brain 148(9):3034\u20133036. https:\/\/doi.org\/10.1093\/brain\/awaf288","journal-title":"Brain"},{"key":"12088_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2024.102453","volume":"89","author":"X Huang","year":"2024","unstructured":"Huang X, Rudensky AY (2024) Regulatory T cells in the context: deciphering the dynamic interplay with the tissue environment. Curr Opin Immunol 89:102453. https:\/\/doi.org\/10.1016\/j.coi.2024.102453","journal-title":"Curr Opin Immunol"},{"issue":"1","key":"12088_CR19","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13024-025-00812-5","volume":"20","author":"S Zhang","year":"2025","unstructured":"Zhang S et al (2025) Peripheral and central neuroimmune mechanisms in Alzheimer\u2019s disease pathogenesis. Mol Neurodegener 20(1):22. https:\/\/doi.org\/10.1186\/s13024-025-00812-5","journal-title":"Mol Neurodegener"},{"issue":"9","key":"12088_CR20","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1038\/s41591-022-01925-w","volume":"28","author":"M Mil\u00e0-Alom\u00e0","year":"2022","unstructured":"Mil\u00e0-Alom\u00e0 M et al (2022) Plasma p-tau231 and p-tau217 as state markers of amyloid-\u03b2 pathology in preclinical Alzheimer\u2019s disease. Nat Med 28(9):1797\u20131801. https:\/\/doi.org\/10.1038\/s41591-022-01925-w","journal-title":"Nat Med"},{"issue":"5","key":"12088_CR21","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202217123","volume":"15","author":"G Salvad\u00f3","year":"2023","unstructured":"Salvad\u00f3 G et al (2023) Specific associations between plasma biomarkers and postmortem amyloid plaque and tau tangle loads. EMBO Mol Med 15(5):e17123. https:\/\/doi.org\/10.15252\/emmm.202217123","journal-title":"EMBO Mol Med"},{"key":"12088_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26104592","author":"S Ding","year":"2025","unstructured":"Ding S, Choi SH, Miller YI (2025) Amyloid \u03b2-induced inflammarafts in Alzheimer\u2019s disease. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms26104592","journal-title":"Int J Mol Sci"},{"issue":"11","key":"12088_CR23","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/s41582-021-00549-x","volume":"17","author":"BM Bettcher","year":"2021","unstructured":"Bettcher BM, Tansey MG, Doroth\u00e9e G, Heneka MT (2021) Peripheral and central immune system crosstalk in Alzheimer disease - a research prospectus. Nat Rev Neurol 17(11):689\u2013701. https:\/\/doi.org\/10.1038\/s41582-021-00549-x","journal-title":"Nat Rev Neurol"},{"key":"12088_CR24","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.brainresbull.2022.02.008","volume":"182","author":"Y Wei","year":"2022","unstructured":"Wei Y et al (2022) Brain-spleen axis in health and diseases: a review and future perspective. Brain Res Bull 182:130\u2013140. https:\/\/doi.org\/10.1016\/j.brainresbull.2022.02.008","journal-title":"Brain Res Bull"},{"issue":"4","key":"12088_CR25","doi-asserted-by":"publisher","first-page":"R375","DOI":"10.1152\/ajpregu.00151.2022","volume":"323","author":"CMD Mota","year":"2022","unstructured":"Mota CMD, Madden CJ (2022) Neural control of the spleen as an effector of immune responses to inflammation: Mechanisms and treatments. Am J Physiol Regul Integr Comp Physiol 323(4):R375\u2013r384. https:\/\/doi.org\/10.1152\/ajpregu.00151.2022","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"1","key":"12088_CR26","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s12974-023-02838-2","volume":"20","author":"N Kobori","year":"2023","unstructured":"Kobori N, Moore AN, Redell JB, Dash PK (2023) Caudal dmn neurons innervate the spleen and release cart peptide to regulate neuroimmune function. J Neuroinflammation 20(1):158. https:\/\/doi.org\/10.1186\/s12974-023-02838-2","journal-title":"J Neuroinflammation"},{"issue":"8","key":"12088_CR27","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1016\/j.neuron.2022.01.010","volume":"110","author":"J Yu","year":"2022","unstructured":"Yu J et al (2022) Neuron-derived neuropeptide Y fine-tunes the splenic immune responses. Neuron 110(8):1327-1339e.e1326. https:\/\/doi.org\/10.1016\/j.neuron.2022.01.010","journal-title":"Neuron"},{"issue":"1","key":"12088_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-023-02902-x","volume":"20","author":"IT Mughrabi","year":"2023","unstructured":"Mughrabi IT et al (2023) Voltammetry in the spleen assesses real-time immunomodulatory norepinephrine release elicited by autonomic neurostimulation. J Neuroinflammation 20(1):236. https:\/\/doi.org\/10.1186\/s12974-023-02902-x","journal-title":"J Neuroinflammation"},{"key":"12088_CR29","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20211604","author":"SN Mueller","year":"2022","unstructured":"Mueller SN (2022) Neural control of immune cell trafficking. J Exp Med. https:\/\/doi.org\/10.1084\/jem.20211604","journal-title":"J Exp Med"},{"issue":"11","key":"12088_CR30","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adq6399","volume":"11","author":"H An","year":"2025","unstructured":"An H et al (2025) Splenic red pulp macrophages eliminate the liver-resistant Streptococcus pneumoniae from the blood circulation of mice. Sci Adv 11(11):eadq6399. https:\/\/doi.org\/10.1126\/sciadv.adq6399","journal-title":"Sci Adv"},{"issue":"10","key":"12088_CR31","doi-asserted-by":"publisher","first-page":"4285","DOI":"10.1038\/s41380-022-01679-4","volume":"27","author":"A Urayama","year":"2022","unstructured":"Urayama A et al (2022) Preventive and therapeutic reduction of amyloid deposition and behavioral impairments in a model of Alzheimer\u2019s disease by whole blood exchange. Mol Psychiatry 27(10):4285\u20134296. https:\/\/doi.org\/10.1038\/s41380-022-01679-4","journal-title":"Mol Psychiatry"},{"issue":"1","key":"12088_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-023-00594-8","volume":"18","author":"ZH Liu","year":"2023","unstructured":"Liu ZH, Wang YJ, Bu XL (2023) Alzheimer\u2019s disease: targeting the peripheral circulation. Mol Neurodegener 18(1):3. https:\/\/doi.org\/10.1186\/s13024-023-00594-8","journal-title":"Mol Neurodegener"},{"key":"12088_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41551-025-01525-2","author":"Y Zhuo","year":"2025","unstructured":"Zhuo Y et al (2025) Targeted clearance of extracellular tau using aptamer-armed monocytes alleviates neuroinflammation in mice with alzheimer\u2019s disease. Nat biomedical Eng. https:\/\/doi.org\/10.1038\/s41551-025-01525-2","journal-title":"Nat biomedical Eng"},{"issue":"4","key":"12088_CR34","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s00401-018-1891-2","volume":"136","author":"J Wang","year":"2018","unstructured":"Wang J et al (2018) Physiological clearance of tau in the periphery and its therapeutic potential for tauopathies. Acta Neuropathol 136(4):525\u2013536. https:\/\/doi.org\/10.1007\/s00401-018-1891-2","journal-title":"Acta Neuropathol"},{"issue":"7","key":"12088_CR35","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1084\/jem.20052362","volume":"203","author":"JM Huston","year":"2006","unstructured":"Huston JM et al (2006) Splenectomy inactivates the cholinergic antiinflammatory pathway during lethal endotoxemia and polymicrobial sepsis. J Exp Med 203(7):1623\u20131628. https:\/\/doi.org\/10.1084\/jem.20052362","journal-title":"J Exp Med"},{"issue":"1","key":"12088_CR36","doi-asserted-by":"publisher","DOI":"10.1007\/s12017-025-08884-8","volume":"27","author":"G Acero","year":"2025","unstructured":"Acero G et al (2025) Splenomegaly, spleen amyloidosis and neutrophil infiltration are present in 3xtg-ad, but not tg-swdi mice. Neuromol Med 27(1):61. https:\/\/doi.org\/10.1007\/s12017-025-08884-8","journal-title":"Neuromol Med"},{"issue":"1","key":"12088_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-024-01492-x","volume":"16","author":"AJ Barber","year":"2024","unstructured":"Barber AJ et al (2024) Age, sex and Alzheimer\u2019s disease: a longitudinal study of 3xtg-ad mice reveals sex-specific disease trajectories and inflammatory responses mirrored in postmortem brains from Alzheimer\u2019s patients. Alzheimers Res Ther 16(1):134. https:\/\/doi.org\/10.1186\/s13195-024-01492-x","journal-title":"Alzheimers Res Ther"},{"issue":"5940","key":"12088_CR38","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1126\/science.1175202","volume":"325","author":"FK Swirski","year":"2009","unstructured":"Swirski FK et al (2009) Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science 325(5940):612\u2013616. https:\/\/doi.org\/10.1126\/science.1175202","journal-title":"Science"},{"issue":"22","key":"12088_CR39","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2022111038","volume":"41","author":"L Xu","year":"2022","unstructured":"Xu L et al (2022) Erythropoietin signaling in peripheral macrophages is required for systemic \u03b2-amyloid clearance. EMBO J 41(22):e111038. https:\/\/doi.org\/10.15252\/embj.2022111038","journal-title":"EMBO J"},{"issue":"1","key":"12088_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-023-00692-7","volume":"18","author":"P Yeapuri","year":"2023","unstructured":"Yeapuri P et al (2023) Amyloid-\u03b2 specific regulatory t cells attenuate Alzheimer\u2019s disease pathobiology in app\/ps1 mice. Mol Neurodegener 18(1):97. https:\/\/doi.org\/10.1186\/s13024-023-00692-7","journal-title":"Mol Neurodegener"},{"issue":"4","key":"12088_CR41","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1007\/s11481-023-10090-x","volume":"18","author":"L Yuan","year":"2023","unstructured":"Yuan L et al (2023) Low-dose il-2 treatment rescues cognitive deficits by repairing the imbalance between treg and th17 cells at the middle Alzheimer\u2019s disease stage. J Neuroimmune Pharmacol 18(4):674\u2013689. https:\/\/doi.org\/10.1007\/s11481-023-10090-x","journal-title":"J Neuroimmune Pharmacol"},{"issue":"2","key":"12088_CR42","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcaa112","volume":"2","author":"A Faridar","year":"2020","unstructured":"Faridar A et al (2020) Restoring regulatory t-cell dysfunction in Alzheimer\u2019s disease through ex vivo expansion. Brain Commun 2(2):fcaa112. https:\/\/doi.org\/10.1093\/braincomms\/fcaa112","journal-title":"Brain Commun"},{"issue":"1","key":"12088_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-025-02326-4","volume":"10","author":"L Wang","year":"2025","unstructured":"Wang L et al (2025) Regulatory t cells in homeostasis and disease: molecular mechanisms and therapeutic potential. Signal Transduct Target Ther 10(1):345. https:\/\/doi.org\/10.1038\/s41392-025-02326-4","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"12088_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-022-01447-z","volume":"10","author":"A Faridar","year":"2022","unstructured":"Faridar A et al (2022) Ex vivo expanded human regulatory T cells modify neuroinflammation in a preclinical model of Alzheimer\u2019s disease. Acta Neuropathol Commun 10(1):144. https:\/\/doi.org\/10.1186\/s40478-022-01447-z","journal-title":"Acta Neuropathol Commun"},{"issue":"7","key":"12088_CR45","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/s41577-024-00994-x","volume":"24","author":"TS Sumida","year":"2024","unstructured":"Sumida TS, Cheru NT, Hafler DA (2024) The regulation and differentiation of regulatory t cells and their dysfunction in autoimmune diseases. Nat Rev Immunol 24(7):503\u2013517. https:\/\/doi.org\/10.1038\/s41577-024-00994-x","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"12088_CR46","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1038\/s41423-023-01036-7","volume":"20","author":"J Wang","year":"2023","unstructured":"Wang J, Zhao X, Wan YY (2023) Intricacies of tgf-\u03b2 signaling in treg and th17 cell biology. Cell Mol Immunol 20(9):1002\u20131022. https:\/\/doi.org\/10.1038\/s41423-023-01036-7","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"12088_CR47","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1097\/tp.0000000000004707","volume":"108","author":"A Huang","year":"2024","unstructured":"Huang A et al (2024) IL-35 stabilizes Treg phenotype to protect cardiac allografts in mice. Transplantation 108(1):161\u2013174. https:\/\/doi.org\/10.1097\/tp.0000000000004707","journal-title":"Transplantation"},{"issue":"9","key":"12088_CR48","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1038\/s41590-022-01289-w","volume":"23","author":"A Kennedy","year":"2022","unstructured":"Kennedy A et al (2022) Differences in CD80 and CD86 transendocytosis reveal CD86 as a key target for CTLA-4 immune regulation. Nat Immunol 23(9):1365\u20131378. https:\/\/doi.org\/10.1038\/s41590-022-01289-w","journal-title":"Nat Immunol"},{"issue":"5","key":"12088_CR49","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2022111556","volume":"42","author":"A Kennedy","year":"2023","unstructured":"Kennedy A et al (2023) The CTLA-4 immune checkpoint protein regulates PD-L1:PD-1 interaction via transendocytosis of its ligand CD80. EMBO J 42(5):e111556. https:\/\/doi.org\/10.15252\/embj.2022111556","journal-title":"EMBO J"},{"key":"12088_CR50","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.79342","author":"O Tsyklauri","year":"2023","unstructured":"Tsyklauri O et al (2023) Regulatory t cells suppress the formation of potent klrk1 and il-7r expressing effector cd8 t cells by limiting il-2. eLife. https:\/\/doi.org\/10.7554\/eLife.79342","journal-title":"eLife"},{"issue":"1","key":"12088_CR51","doi-asserted-by":"publisher","DOI":"10.1093\/immadv\/ltad007","volume":"3","author":"S Sakaguchi","year":"2023","unstructured":"Sakaguchi S, Kawakami R, Mikami N (2023) Treg-based immunotherapy for antigen-specific immune suppression and stable tolerance induction: a perspective. Immunother Adv 3(1):ltad007. https:\/\/doi.org\/10.1093\/immadv\/ltad007","journal-title":"Immunother Adv"},{"issue":"4","key":"12088_CR52","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.immuni.2018.07.015","volume":"49","author":"JD Proto","year":"2018","unstructured":"Proto JD et al (2018) Regulatory T cells promote macrophage efferocytosis during inflammation resolution. Immunity 49(4):666-677.e666. https:\/\/doi.org\/10.1016\/j.immuni.2018.07.015","journal-title":"Immunity"},{"issue":"1","key":"12088_CR53","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13024-021-00458-z","volume":"16","author":"H Ben-Yehuda","year":"2021","unstructured":"Ben-Yehuda H et al (2021) Key role of the ccr2-ccl2 axis in disease modification in a mouse model of tauopathy. Mol Neurodegener 16(1):39. https:\/\/doi.org\/10.1186\/s13024-021-00458-z","journal-title":"Mol Neurodegener"},{"issue":"8","key":"12088_CR54","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/s41577-025-01149-2","volume":"25","author":"W Piao","year":"2025","unstructured":"Piao W et al (2025) Regulatory t cell and endothelial cell crosstalk. Nat Rev Immunol 25(8):588\u2013607. https:\/\/doi.org\/10.1038\/s41577-025-01149-2","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"12088_CR55","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s00395-024-01035-3","volume":"119","author":"N Gladow","year":"2024","unstructured":"Gladow N et al (2024) Role of cd4(+) t-cells for regulating splenic myelopoiesis and monocyte differentiation after experimental myocardial infarction. Basic Res Cardiol 119(2):261\u2013275. https:\/\/doi.org\/10.1007\/s00395-024-01035-3","journal-title":"Basic Res Cardiol"},{"issue":"5","key":"12088_CR56","doi-asserted-by":"publisher","first-page":"3522","DOI":"10.4049\/jimmunol.0900620","volume":"183","author":"V Zota","year":"2009","unstructured":"Zota V et al (2009) Hla-dr alleles in amyloid beta-peptide autoimmunity: A highly immunogenic role for the drb1*1501 allele. Journal of immunology (Baltimore, Md\u202f: 1950) 183(5):3522\u20133530. https:\/\/doi.org\/10.4049\/jimmunol.0900620","journal-title":"Journal of immunology (Baltimore, Md : 1950)"},{"issue":"18","key":"12088_CR57","doi-asserted-by":"publisher","first-page":"7668","DOI":"10.7150\/thno.75965","volume":"12","author":"H Yang","year":"2022","unstructured":"Yang H et al (2022) Adoptive therapy with amyloid-\u03b2 specific regulatory t cells alleviates alzheimer\u2019s disease. Theranostics 12(18):7668\u20137680. https:\/\/doi.org\/10.7150\/thno.75965","journal-title":"Theranostics"},{"issue":"9","key":"12088_CR58","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1212\/01.Wnl.0000159740.16984.3c","volume":"64","author":"S Gilman","year":"2005","unstructured":"Gilman S et al (2005) Clinical effects of abeta immunization (an1792) in patients with ad in an interrupted trial. Neurology 64(9):1553\u20131562. https:\/\/doi.org\/10.1212\/01.Wnl.0000159740.16984.3c","journal-title":"Neurology"},{"issue":"1","key":"12088_CR59","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-022-00292-3","volume":"11","author":"C Song","year":"2022","unstructured":"Song C et al (2022) Immunotherapy for alzheimer\u2019s disease: Targeting \u03b2-amyloid and beyond. Transl Neurodegener 11(1):18. https:\/\/doi.org\/10.1186\/s40035-022-00292-3","journal-title":"Transl Neurodegener"},{"issue":"1","key":"12088_CR60","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s13195-025-01791-x","volume":"17","author":"A Faridar","year":"2025","unstructured":"Faridar A et al (2025) Low-dose interleukin-2 in patients with mild to moderate alzheimer\u2019s disease: A randomized clinical trial. Alzheimers Res Ther 17(1):146. https:\/\/doi.org\/10.1186\/s13195-025-01791-x","journal-title":"Alzheimers Res Ther"},{"key":"12088_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2023.104778","volume":"393\u2013394","author":"A Jafarzadeh","year":"2023","unstructured":"Jafarzadeh A, Sheikhi A, Jafarzadeh Z, Nemati M (2023) Differential roles of regulatory t cells in Alzheimer\u2019s disease. Cell Immunol 393\u2013394:104778. https:\/\/doi.org\/10.1016\/j.cellimm.2023.104778","journal-title":"Cell Immunol"},{"issue":"8","key":"12088_CR62","doi-asserted-by":"publisher","DOI":"10.1093\/pnasnexus\/pgad251","volume":"2","author":"EJ Yang","year":"2023","unstructured":"Yang EJ, Rahim MA, Griggs E, Iban-Arias R, Pasinetti GM (2023) Transient anxiety-and depression-like behaviors are linked to the depletion of foxp3-expressing cells via inflammasome in the brain. PNAS Nexus 2(8):pgad251. https:\/\/doi.org\/10.1093\/pnasnexus\/pgad251","journal-title":"PNAS Nexus"},{"issue":"1","key":"12088_CR63","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-023-02702-3","volume":"20","author":"G Stym-Popper","year":"2023","unstructured":"Stym-Popper G et al (2023) Regulatory t cells decrease c3-positive reactive astrocytes in Alzheimer-like pathology. J Neuroinflammation 20(1):64. https:\/\/doi.org\/10.1186\/s12974-023-02702-3","journal-title":"J Neuroinflammation"},{"issue":"1","key":"12088_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-45433-3","volume":"9","author":"F Ciccocioppo","year":"2019","unstructured":"Ciccocioppo F et al (2019) The characterization of regulatory t-cell profiles in Alzheimer\u2019s disease and multiple sclerosis. Sci Rep 9(1):8788. https:\/\/doi.org\/10.1038\/s41598-019-45433-3","journal-title":"Sci Rep"},{"key":"12088_CR65","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.jconrel.2024.05.007","volume":"370","author":"Z Huang","year":"2024","unstructured":"Huang Z et al (2024) Spleen-targeted delivery systems and strategies for spleen-related diseases. J Control Release 370:773\u2013797. https:\/\/doi.org\/10.1016\/j.jconrel.2024.05.007","journal-title":"J Control Release"},{"key":"12088_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms8967","volume":"6","author":"K Baruch","year":"2015","unstructured":"Baruch K et al (2015) Breaking immune tolerance by targeting foxp3(+) regulatory t cells mitigates Alzheimer\u2019s disease pathology. Nat Commun 6:7967. https:\/\/doi.org\/10.1038\/ncomms8967","journal-title":"Nat Commun"},{"issue":"2","key":"12088_CR67","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/s41573-024-01089-x","volume":"24","author":"CM Wardell","year":"2025","unstructured":"Wardell CM, Boardman DA, Levings MK (2025) Harnessing the biology of regulatory t cells to treat disease. Nat Rev Drug Discovery 24(2):93\u2013111. https:\/\/doi.org\/10.1038\/s41573-024-01089-x","journal-title":"Nat Rev Drug Discovery"},{"issue":"1","key":"12088_CR68","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34162-3","volume":"13","author":"JY Zhang","year":"2022","unstructured":"Zhang JY et al (2022) Low-dose il-2 reduces il-21(+) t cell frequency and induces anti-inflammatory gene expression in type 1 diabetes. Nat Commun 13(1):7324. https:\/\/doi.org\/10.1038\/s41467-022-34162-3","journal-title":"Nat Commun"},{"issue":"1","key":"12088_CR69","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-023-00387-5","volume":"12","author":"A Faridar","year":"2023","unstructured":"Faridar A et al (2023) A phase 1 open-label pilot study of low-dose Interleukine-2 immunotherapy in patients with Alzheimer\u2019s disease. Transl Neurodegener 12(1):54. https:\/\/doi.org\/10.1186\/s40035-023-00387-5","journal-title":"Transl Neurodegener"},{"issue":"1","key":"12088_CR70","doi-asserted-by":"publisher","DOI":"10.1080\/15476278.2022.2164159","volume":"19","author":"KJ Baron","year":"2023","unstructured":"Baron KJ, Turnquist HR (2023) Clinical manufacturing of regulatory T cell products for adoptive cell therapy and strategies to improve therapeutic efficacy. Organogenesis 19(1):2164159. https:\/\/doi.org\/10.1080\/15476278.2022.2164159","journal-title":"Organogenesis"},{"issue":"43","key":"12088_CR71","doi-asserted-by":"publisher","first-page":"69347","DOI":"10.18632\/oncotarget.12469","volume":"7","author":"H Baek","year":"2016","unstructured":"Baek H et al (2016) Neuroprotective effects of CD4\u2009+\u2009CD25+FoxP3\u2009+\u2009regulatory T cells in a 3xTg-AD Alzheimer\u2019s disease model. Oncotarget 7(43):69347\u201369357. https:\/\/doi.org\/10.18632\/oncotarget.12469","journal-title":"Oncotarget"},{"issue":"6","key":"12088_CR72","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.it.2023.04.005","volume":"44","author":"S Bittner","year":"2023","unstructured":"Bittner S, Hehlgans T, Feuerer M (2023) Engineered treg cells as putative therapeutics against inflammatory diseases and beyond. Trends Immunol 44(6):468\u2013483. https:\/\/doi.org\/10.1016\/j.it.2023.04.005","journal-title":"Trends Immunol"},{"issue":"1","key":"12088_CR73","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/j.1365-2249.2008.03734.x","volume":"154","author":"MM Vel\u00e1squez-Lopera","year":"2008","unstructured":"Vel\u00e1squez-Lopera MM, Correa LA, Garc\u00eda LF (2008) Human spleen contains different subsets of dendritic cells and regulatory t lymphocytes. Clin Exp Immunol 154(1):107\u2013114. https:\/\/doi.org\/10.1111\/j.1365-2249.2008.03734.x","journal-title":"Clin Exp Immunol"},{"issue":"7","key":"12088_CR74","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.4049\/jimmunol.1600974","volume":"197","author":"JM Stolley","year":"2016","unstructured":"Stolley JM, Campbell DJ (2016) A 33D1\u2009+\u2009dendritic cell\/autoreactive CD4\u2009+\u2009T cell circuit maintains IL-2-dependent regulatory T cells in the spleen. J Immunol 197(7):2635\u20132645. https:\/\/doi.org\/10.4049\/jimmunol.1600974","journal-title":"J Immunol"},{"key":"12088_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.117721","volume":"181","author":"H Yang","year":"2024","unstructured":"Yang H et al (2024) A preclinical and phase I clinical study of ex vivo-expanded Amyloid Beta-specific human regulatory T cells in Alzheimer\u2019s disease. Biomed Pharmacother 181:117721. https:\/\/doi.org\/10.1016\/j.biopha.2024.117721","journal-title":"Biomed Pharmacother"},{"key":"12088_CR76","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2023.1125492","volume":"17","author":"T Simon","year":"2023","unstructured":"Simon T et al (2023) The cholinergic anti-inflammatory pathway inhibits inflammation without lymphocyte relay. Front Neurosci 17:1125492. https:\/\/doi.org\/10.3389\/fnins.2023.1125492","journal-title":"Front Neurosci"},{"issue":"7","key":"12088_CR77","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1016\/j.celrep.2019.01.070","volume":"26","author":"G Garg","year":"2019","unstructured":"Garg G et al (2019) Blimp1 prevents methylation of foxp3 and loss of regulatory t cell identity at sites of inflammation. Cell Rep 26(7):1854-1868e.e1855. https:\/\/doi.org\/10.1016\/j.celrep.2019.01.070","journal-title":"Cell Rep"},{"issue":"7","key":"12088_CR78","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/s41590-018-0120-4","volume":"19","author":"M Dominguez-Villar","year":"2018","unstructured":"Dominguez-Villar M, Hafler DA (2018) Regulatory t cells in autoimmune disease. Nat Immunol 19(7):665\u2013673. https:\/\/doi.org\/10.1038\/s41590-018-0120-4","journal-title":"Nat Immunol"},{"issue":"1","key":"12088_CR79","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s42234-024-00162-5","volume":"10","author":"F Hesampour","year":"2024","unstructured":"Hesampour F, Tshikudi DM, Bernstein CN, Ghia JE (2024) Exploring the efficacy of transcutaneous auricular vagus nerve stimulation (tavns) in modulating local and systemic inflammation in experimental models of colitis. Bioelectronic Med 10(1):29. https:\/\/doi.org\/10.1186\/s42234-024-00162-5","journal-title":"Bioelectronic Med"},{"key":"12088_CR80","doi-asserted-by":"publisher","DOI":"10.34133\/research.0013","volume":"2022","author":"X Hu","year":"2022","unstructured":"Hu X et al (2022) Noninvasive low-frequency pulsed focused ultrasound therapy for rheumatoid arthritis in mice. Research (Washington, DC) 2022:0013. https:\/\/doi.org\/10.34133\/research.0013","journal-title":"Research (Washington, DC)"},{"issue":"3","key":"12088_CR81","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.brs.2023.04.003","volume":"16","author":"S Zanos","year":"2023","unstructured":"Zanos S et al (2023) Focused ultrasound neuromodulation of the spleen activates an anti-inflammatory response in humans. Brain Stimul 16(3):703\u2013711. https:\/\/doi.org\/10.1016\/j.brs.2023.04.003","journal-title":"Brain Stimul"},{"key":"12088_CR82","doi-asserted-by":"publisher","DOI":"10.3389\/fnhum.2022.866434","volume":"16","author":"M Vargas-Caballero","year":"2022","unstructured":"Vargas-Caballero M et al (2022) Vagus nerve stimulation as a potential therapy in early Alzheimer\u2019s disease: a review. Front Hum Neurosci 16:866434. https:\/\/doi.org\/10.3389\/fnhum.2022.866434","journal-title":"Front Hum Neurosci"},{"issue":"1","key":"12088_CR83","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"CH van Dyck","year":"2023","unstructured":"van Dyck CH et al (2023) Lecanemab in early Alzheimer\u2019s disease. N Engl J Med 388(1):9\u201321. https:\/\/doi.org\/10.1056\/NEJMoa2212948","journal-title":"N Engl J Med"},{"issue":"4","key":"12088_CR84","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/s41582-024-01053-8","volume":"21","author":"SM Greenberg","year":"2025","unstructured":"Greenberg SM, Bax F, van Veluw SJ (2025) Amyloid-related imaging abnormalities: Manifestations, metrics and mechanisms. Nat reviews Neurol 21(4):193\u2013203. https:\/\/doi.org\/10.1038\/s41582-024-01053-8","journal-title":"Nat reviews Neurol"},{"issue":"12","key":"12088_CR85","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1038\/s41573-024-01053-9","volume":"23","author":"M Croft","year":"2024","unstructured":"Croft M, Salek-Ardakani S, Ware CF (2024) Targeting the tnf and tnfr superfamilies in autoimmune disease and cancer. Nat Rev Drug Discovery 23(12):939\u2013961. https:\/\/doi.org\/10.1038\/s41573-024-01053-9","journal-title":"Nat Rev Drug Discovery"},{"issue":"1","key":"12088_CR86","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-024-01023-8","volume":"31","author":"IT Chyuan","year":"2024","unstructured":"Chyuan IT et al (2024) Association of TRAIL receptor with phosphatase SHP-1 enables repressing T cell receptor signaling and T cell activation through inactivating LCK. J Biomed Sci 31(1):33. https:\/\/doi.org\/10.1186\/s12929-024-01023-8","journal-title":"J Biomed Sci"},{"issue":"1","key":"12088_CR87","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-024-03208-2","volume":"21","author":"J Zou","year":"2024","unstructured":"Zou J et al (2024) Microglia either promote or restrain TRAIL-mediated excitotoxicity caused by A\u03b2(1\u201342) oligomers. J Neuroinflammation 21(1):215. https:\/\/doi.org\/10.1186\/s12974-024-03208-2","journal-title":"J Neuroinflammation"},{"issue":"Pt 1","key":"12088_CR88","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1093\/brain\/awu318","volume":"138","author":"G Cantarella","year":"2015","unstructured":"Cantarella G et al (2015) Neutralization of TNFSF10 ameliorates functional outcome in a murine model of Alzheimer\u2019s disease. Brain 138(Pt 1):203\u2013216. https:\/\/doi.org\/10.1093\/brain\/awu318","journal-title":"Brain"},{"key":"12088_CR89","doi-asserted-by":"publisher","DOI":"10.1038\/s41583-025-00997-0","author":"O Butovsky","year":"2025","unstructured":"Butovsky O et al (2025) Immune dysfunction in Alzheimer disease. Nat Rev Neurosci. https:\/\/doi.org\/10.1038\/s41583-025-00997-0","journal-title":"Nat Rev Neurosci"},{"issue":"5","key":"12088_CR90","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/s41577-024-01104-7","volume":"25","author":"MT Heneka","year":"2025","unstructured":"Heneka MT et al (2025) Neuroinflammation in Alzheimer disease. Nat Rev Immunol 25(5):321\u2013352. https:\/\/doi.org\/10.1038\/s41577-024-01104-7","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"12088_CR91","doi-asserted-by":"publisher","DOI":"10.1002\/alz.71243","volume":"22","author":"J Yan","year":"2026","unstructured":"Yan J et al (2026) The spleen-brain axis in Alzheimer\u2019s disease and related dementias: Integrating immune and metabolic regulation. Alzheimers Dement 22(3):e71243. https:\/\/doi.org\/10.1002\/alz.71243","journal-title":"Alzheimers Dement"},{"key":"12088_CR92","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1616939","volume":"16","author":"Y Cao","year":"2025","unstructured":"Cao Y et al (2025) The role of peripheral innate immune cells in Alzheimer\u2019s disease progression. Front Immunol 16:1616939. https:\/\/doi.org\/10.3389\/fimmu.2025.1616939","journal-title":"Front Immunol"},{"key":"12088_CR93","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112328","volume":"135","author":"R Arfaei","year":"2024","unstructured":"Arfaei R et al (2024) Decoding the role of the CCL2\/CCR2 axis in Alzheimer\u2019s disease and innovating therapeutic approaches: Keeping all options open. Int Immunopharmacol 135:112328. https:\/\/doi.org\/10.1016\/j.intimp.2024.112328","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"12088_CR94","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s13195-023-01254-1","volume":"15","author":"F Zhou","year":"2023","unstructured":"Zhou F, Sun Y, Xie X, Zhao Y (2023) Blood and csf chemokines in alzheimer\u2019s disease and mild cognitive impairment: A systematic review and meta-analysis. Alzheimers Res Ther 15(1):107. https:\/\/doi.org\/10.1186\/s13195-023-01254-1","journal-title":"Alzheimers Res Ther"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12088-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12088-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12088-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T08:33:46Z","timestamp":1780994026000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12088-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,9]]},"references-count":94,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12088"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12088-z","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,9]]},"assertion":[{"value":"28 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"912"}}